Lyka Labs Ltd (LYKALABS)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Lyka Labs Ltd (LYKALABS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013610
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lyka Labs Ltd (Lyka Labs) is a developer and manufacturer of pharmaceutical formulations and active pharmaceutical ingredients. The company offers development of various formulations which include lyophilized injections, differentiated dermatological formulation, dry powder injections, and others. It also offers manufacturing services to wide range of pharmaceutical companies. Lyka Labs offers formulation development programs such as product and process optimization, analytical method development, analytical method validation, evaluation and techno-marketing studies, and technology transfer programs. The company markets its products in Romania, Sudan, Ukraine, Venezuela, Vietnam, Combodia, Costa Rica and others. It operates manufacturing facilities in Ankleshwar and Tarapur. Lyka Labs is headquartered in Mumbai, Maharashtra, India.

Lyka Labs Ltd (LYKALABS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Lyka Labs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Lyka Labs Enters Into Technology Transfer Agreement With A Turkish-Based Pharma Company 11
Licensing Agreements 12
Lyka Labs Enters into Licensing Agreement for 12 Sterlite Injectable Formulations 12
Equity Offering 13
Lyka Labs Raises USD5.2 Million in Rights Offering of Shares 13
Asset Transactions 14
Alivira Animal Health to Acquire Veterinary Business from Lyka Labs 14
Lyka Labs Sells Manufacturing Unit for USD6.3 Million 15
Lyka Labs Ltd – Key Competitors 16
Lyka Labs Ltd – Key Employees 17
Lyka Labs Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Apr 11, 2016: Lyka Labs: Launch of New Marketing Divisions 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Lyka Labs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Lyka Labs Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Lyka Labs Enters Into Technology Transfer Agreement With A Turkish-Based Pharma Company 11
Lyka Labs Enters into Licensing Agreement for 12 Sterlite Injectable Formulations 12
Lyka Labs Raises USD5.2 Million in Rights Offering of Shares 13
Alivira Animal Health to Acquire Veterinary Business from Lyka Labs 14
Lyka Labs Sells Manufacturing Unit for USD6.3 Million 15
Lyka Labs Ltd, Key Competitors 16
Lyka Labs Ltd, Key Employees 17
Lyka Labs Ltd, Other Locations 18
Lyka Labs Ltd, Subsidiaries 18

★海外企業調査レポート[Lyka Labs Ltd (LYKALABS)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sinovel Wind Group Co Ltd (601558):企業の財務・戦略的SWOT分析
    Summary Sinovel Wind Group Co Ltd (Sinovel) is a wind turbine manufacturing company. The company designs, manufactures, develops, and commercializes the large-scale of onshore, offshore and intertidal wind turbines. Its products include SL1500 series wind turbines, SL2000 series wind turbines, SL300 …
  • Army and Air Force Exchange Service:企業の戦略・SWOT・財務情報
    Army and Air Force Exchange Service - Strategy, SWOT and Corporate Finance Report Summary Army and Air Force Exchange Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Abg Sundal Collier Holding Asa:企業の戦略・SWOT・財務分析
    Abg Sundal Collier Holding Asa - Strategy, SWOT and Corporate Finance Report Summary Abg Sundal Collier Holding Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Mckesson Europe AG (CLS1):企業の財務・戦略的SWOT分析
    Mckesson Europe AG (CLS1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ossur hf (OSSR):企業の財務・戦略的SWOT分析
    Ossur hf (OSSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • TerSera Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary TerSera Therapeutics LLC (TerSera Therapeutics) is a pharmaceutical company that develops of specialty pharmaceutical products. The company offers ergotamine tartrate sublingual tablets, goserelin acetate implant, zoladex, and zoladex la. It develops products in the therapeutic areas of alle …
  • Princeton University-製薬・医療分野:企業M&A・提携分析
    Summary Princeton University (Princeton) is a research university that provides undergraduate and graduate instruction. The university offer education in the areas of humanities, social sciences, natural sciences and engineering. It provides services such as health services, event planning, external …
  • Murree Brewery Co. Ltd.:企業の戦略・SWOT・財務分析
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Vast Resources Plc:企業の戦略・SWOT・財務分析
    Vast Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vast Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Praxair Inc (PX)-エネルギー分野:企業M&A・提携分析
    Summary Praxair Inc (Praxair) is a producer and supplier of industrial gases. The company offers atmospheric gases including oxygen, nitrogen, argon and rare gases, and process gases such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases and acetylene. It also designs and builds …
  • Croma-Pharma GmbH-医療機器分野:企業M&A・提携分析
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise …
  • Second Sight Medical Products Inc (EYES):医療機器:M&Aディール及び事業提携情報
    Summary Second Sight Medical Products Inc (Second Sight) is a medical device company that develops, manufactures and markets implantable visual prosthetics for blind individuals. The company offers Argus II retinal prosthesis system, a device that restores some functional vision for people suffering …
  • Baldwin & Lyons Inc:企業の戦略・SWOT・財務情報
    Baldwin & Lyons Inc - Strategy, SWOT and Corporate Finance Report Summary Baldwin & Lyons Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Fresenius Medical Care AG & Co. KGaA:企業の戦略・SWOT・財務分析
    Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Interprotein Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Interprotein Corp (Interprotein) is a drug development company that develops active modulators for protein-protein interaction (PPI) targets. The company offers products such as IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E …
  • AGL Energy Limited:企業の戦略・SWOT・財務分析
    AGL Energy Limited - Strategy, SWOT and Corporate Finance Report Summary AGL Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SGS SA (SGSN):製薬・医療:M&Aディール及び事業提携情報
    Summary SGS SA (SGS) is a provider of inspection, verification, testing, certification and quality assurance services. The company also provides risk management, consultancy, sustainability solutions and training services. SGS inspects, samples, analyzes, and monitors raw materials, components and p …
  • Symrise AG (SY1):企業の財務・戦略的SWOT分析
    Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kadmon Holdings Inc (KDMN):製薬・医療:M&Aディール及び事業提携情報
    Summary Kadmon Holdings Inc (Kadmon) is an integrated biopharmaceutical company that discovers, develops and markets small molecules and biologics for autoimmune and fibrotic diseases, various types of cancer, and genetic diseases. The company’s pipeline encompasses investigational candidates for th …
  • Hanwha Solutions Corp (009830):企業の財務・戦略的SWOT分析
    Summary Hanwha Solutions Corp (Hanwha Solutions), a subsidiary of Hanwha Corp, is a provider of chemicals, solar energy solutions and advanced industrial materials. The company is engaged in the production of inorganic chemical, plastic and polymer products which include chlorine and caustic soda, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆